Literature DB >> 21652087

Egg yolk IgY: protection against rotavirus induced diarrhea and modulatory effect on the systemic and mucosal antibody responses in newborn calves.

C Vega1, M Bok, P Chacana, L Saif, F Fernandez, V Parreño.   

Abstract

Bovine rotavirus (BRV) is an important cause of diarrhea in newborn calves. Local passive immunity is the most efficient protective strategy to control the disease. IgY technology (the use of chicken egg yolk immunoglobulins) is an economic and practical alternative to prevent BRV diarrhea in dairy calves. The aim of this study was to evaluate the protection and immunomodulation induced by the oral administration of egg yolk enriched in BRV specific IgY to experimentally BRV infected calves. All calves in groups Gp 1, 2 and 3 received control colostrum (CC; BRV virus neutralization Ab titer - VN=65,536; ELISA BRV IgG(1)=16,384) prior to gut closure. After gut closure, calves received milk supplemented with 6% BRV-immune egg yolk [(Gp 1) VN=2048; ELISA IgY Ab titer=4096] or non-immune control egg yolk [(Gp 2) VN<4; ELISA IgY Ab titer<4] twice a day, for 14 days. Calves receiving CC only or colostrum deprived calves (CD) fed antibody (Ab) free milk served as controls (Gp 3 and 4, respectively). Calves were inoculated with 10(5.85)focus forming units (FFU) of virulent BRV IND at 2 days of age. Control calves (Gp 3 and 4) and calves fed control IgY (Gp 2) were infected and developed severe diarrhea. Around 80% calves in Gp 1 (IgY 4096) were infected, but they showed 80% (4/5) protection against BRV diarrhea. Bovine RV-specific IgY Ab were detected in the feces of calves in Gp 1, indicating that avian antibodies (Abs) remained intact after passage through the gastrointestinal tract. At post infection day 21, the duodenum was the major site of BRV specific antibody secreting cells (ASC) in all experimental groups. Mucosal ASC responses of all isotypes were significantly higher in the IgY treated groups, independently of the specificity of the treatment, indicating that egg yolk components modulated the immune response against BRV infection at the mucosal level. These results indicate that supplementing newborn calves' diets for the first 14 days of life with egg yolk enriched in BRV-specific IgY represents a promising strategy to prevent BRV diarrhea. Moreover a strong active ASC immune response is induced in the intestinal mucosa following BRV infection after the administration of egg yolk, regardless the specificity of the treatment.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21652087      PMCID: PMC3155943          DOI: 10.1016/j.vetimm.2011.05.003

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  37 in total

Review 1.  Pathogenesis of intestinal and systemic rotavirus infection.

Authors:  Robert F Ramig
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

2.  Molecular characterization of bovine rotavirus circulating in beef and dairy herds in Argentina during a 10-year period (1994-2003).

Authors:  L Garaicoechea; K Bok; L R Jones; G Combessies; A Odeón; F Fernandez; V Parreño
Journal:  Vet Microbiol       Date:  2006-09-18       Impact factor: 3.293

Review 3.  Group A rotavirus veterinary vaccines.

Authors:  L J Saif; F M Fernandez
Journal:  J Infect Dis       Date:  1996-09       Impact factor: 5.226

4.  Lysophosphatidylcholine is a natural adjuvant that initiates cellular immune responses.

Authors:  Laure Perrin-Cocon; Sophie Agaugué; Frédéric Coutant; Pierre Saint-Mézard; Aurélie Guironnet-Paquet; Jean-François Nicolas; Patrice André; Vincent Lotteau
Journal:  Vaccine       Date:  2005-09-30       Impact factor: 3.641

5.  Egg Yolk Antibodies, State of the Art and Future Prospects.

Authors:  Rüdiger Schade; Andreas Hlinak
Journal:  ALTEX       Date:  1996       Impact factor: 6.043

6.  Comparative analysis of innate immune responses following infection of newborn calves with bovine rotavirus and bovine coronavirus.

Authors:  Palok Aich; Heather L Wilson; Radhey S Kaushik; Andy A Potter; Lorne A Babiuk; Philip Griebel
Journal:  J Gen Virol       Date:  2007-10       Impact factor: 3.891

7.  Serum and intestinal isotype antibody responses and correlates of protective immunity to human rotavirus in a gnotobiotic pig model of disease.

Authors:  T L Tô; L A Ward; L Yuan; L J Saif
Journal:  J Gen Virol       Date:  1998-11       Impact factor: 3.891

8.  First isolation of rotavirus associated with neonatal diarrhoea in guanacos (Lama guanicoe) in the Argentinean Patagonia region.

Authors:  V Parreño; V Constantini; S Cheetham; J Blanco Viera; L J Saif; F Fernández; L Leoni; A Schudel
Journal:  J Vet Med B Infect Dis Vet Public Health       Date:  2001-11

9.  Passive immunity to bovine rotavirus in newborn calves fed colostrum supplements from cows immunized with recombinant SA11 rotavirus core-like particle (CLP) or virus-like particle (VLP) vaccines.

Authors:  F M Fernandez; M E Conner; D C Hodgins; A V Parwani; P R Nielsen; S E Crawford; M K Estes; L J Saif
Journal:  Vaccine       Date:  1998-03       Impact factor: 3.641

10.  Modulation by colostrum-acquired maternal antibodies of systemic and mucosal antibody responses to rotavirus in calves experimentally challenged with bovine rotavirus.

Authors:  V Parreño; C Béjar; A Vagnozzi; M Barrandeguy; V Costantini; M I Craig; L Yuan; D Hodgins; L Saif; F Fernández
Journal:  Vet Immunol Immunopathol       Date:  2004-07       Impact factor: 2.046

View more
  23 in total

1.  Development of anti-Helicobacter pylori immunoglobulins Y (IgYs) in quail.

Authors:  S Najdi; G Nikbakht Brujeni; N Sheikhi; S Chakhkar
Journal:  Iran J Vet Res       Date:  2016       Impact factor: 1.376

Review 2.  Monoclonal antibodies: Principles and applications of immmunodiagnosis and immunotherapy for hepatitis C virus.

Authors:  Ashraf Tabll; Aymn T Abbas; Sherif El-Kafrawy; Ahmed Wahid
Journal:  World J Hepatol       Date:  2015-10-08

3.  Evaluation of anti-norovirus IgY from egg yolk of chickens immunized with norovirus P particles.

Authors:  Ying-Chun Dai; Yun-Yun Wang; Xu-Fu Zhang; Ming Tan; Ming Xia; Xian-Bo Wu; Xi Jiang; Jun Nie
Journal:  J Virol Methods       Date:  2012-08-04       Impact factor: 2.014

4.  A dual chicken IgY against rotavirus and norovirus.

Authors:  Ying-Chun Dai; Xu-Fu Zhang; Ming Tan; Pengwei Huang; Wen Lei; Hao Fang; Weiming Zhong; Xi Jiang
Journal:  Antiviral Res       Date:  2012-12-22       Impact factor: 5.970

5.  Effect of Replacing in-Feed Antibiotic Growth Promoters with a Combination of Egg Immunoglobulins and Phytomolecules on the Performance, Serum Immunity, and Intestinal Health of Weaned Pigs Challenged with Escherichia coli K88.

Authors:  Yunsheng Han; Tengfei Zhan; Chaohua Tang; Qingyu Zhao; Dieudonné M Dansou; Yanan Yu; Fellipe F Barbosa; Junmin Zhang
Journal:  Animals (Basel)       Date:  2021-04-30       Impact factor: 2.752

6.  Effect of immunized egg proteins on the performance and neonatal diarrhoea incidence in newborn calves.

Authors:  Sandra van Kuijk; Ruth Kinkead; Gillian Scoley; Steven Morrison; Yanming Han
Journal:  J Anim Physiol Anim Nutr (Berl)       Date:  2021-01-19       Impact factor: 2.718

7.  Protection Efficacy of Multivalent Egg Yolk Immunoglobulin against Eimeria tenella Infection in Chickens.

Authors:  Jj Xu; Cz Ren; Ss Wang; Dd Liu; Lq Cao; Jp Tao
Journal:  Iran J Parasitol       Date:  2013-07       Impact factor: 1.012

Review 8.  Effect of chicken egg yolk antibodies (IgY) against diarrhea in domesticated animals: a systematic review and meta-analysis.

Authors:  Thirumalai Diraviyam; Bin Zhao; Yuan Wang; Ruediger Schade; Antonysamy Michael; Xiaoying Zhang
Journal:  PLoS One       Date:  2014-05-20       Impact factor: 3.240

9.  IgY antibodies protect against human Rotavirus induced diarrhea in the neonatal gnotobiotic piglet disease model.

Authors:  Celina G Vega; Marina Bok; Anastasia N Vlasova; Kuldeep S Chattha; Fernando M Fernández; Andrés Wigdorovitz; Viviana G Parreño; Linda J Saif
Journal:  PLoS One       Date:  2012-08-03       Impact factor: 3.240

Review 10.  Immunoglobulin Y for Potential Diagnostic and Therapeutic Applications in Infectious Diseases.

Authors:  Lucia Lee; Kate Samardzic; Michael Wallach; Lyn R Frumkin; Daria Mochly-Rosen
Journal:  Front Immunol       Date:  2021-06-09       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.